Literature DB >> 32113941

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.

Alexander J Stratigos1, Claus Garbe2, Clio Dessinioti3, Celeste Lebbe4, Veronique Bataille5, Lars Bastholt6, Brigitte Dreno7, Maria Concetta Fargnoli8, Ana Maria Forsea9, Cecille Frenard7, Catherine Α Harwood10, Axel Hauschild11, Christoph Hoeller12, Lidija Kandolf-Sekulovic13, R Kaufmann14, Nicole Wj Kelleners-Smeets15, Josep Malvehy16, Veronique Del Marmol17, Mark R Middleton18, David Moreno-Ramirez19, Giovanni Pellecani20, Ketty Peris21, Philippe Saiag22, Marieke H J van den Beuken-van Everdingen23, Ricardo Vieira24, Iris Zalaudek25, Alexander M M Eggermont26, Jean-Jacques Grob27.   

Abstract

Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (<4%). Further risk stratification into low-risk or high-risk common primary cSCC is recommended based on proposed high-risk factors. Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) including locoregional metastatic or distant metastatic cSCC. Current systems used for staging include the American Joint Committee on Cancer (AJCC) 8th edition, the Union for International Cancer Control (UICC) 8th edition, and Brigham and Women's Hospital (BWH) system. Physical examination for all cSCCs should include total body skin examination and clinical palpation of lymph nodes, especially of the draining basins. Radiologic imaging such as ultrasound of the regional lymph nodes, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT) scans are recommended for staging of high-risk cSCC. Sentinel lymph node biopsy is currently not recommended. Nicotinamide, oral retinoids, and topical 5-FU have been used for the chemoprevention of subsequent cSCCs in high-risk patients but are not routinely recommended. Education about sun protection measures including reducing sun exposure, use of protective clothing, regular use of sunscreens and avoidance of artificial tanning, is recommended.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; High-risk common primary cSCC; Imaging; Invasive cutaneous squamous cell carcinoma; Locally advanced Cscc; Low-risk; Metastatic cSCC; Prevention; Prognosis; Staging

Year:  2020        PMID: 32113941     DOI: 10.1016/j.ejca.2020.01.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Non-Melanoma Skin Cancer: Statistical Associations between Clinical Parameters.

Authors:  Alexandra-Roxana Ciuciulete; Alex Emilian Stepan; Bianca Cătălina Andreiana; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2022-03-31

2.  Curettage and electrodessication combined with photodynamic therapy in the treatment of large squamous cell carcinomas in unfit and frail patients.

Authors:  Henrik Luu; Måns Cornefjord; Åke Svensson; Henry Svensson
Journal:  BMJ Case Rep       Date:  2022-06-01

Review 3.  Immune Checkpoint Inhibitors in Cancer Therapy.

Authors:  Yavar Shiravand; Faezeh Khodadadi; Seyyed Mohammad Amin Kashani; Seyed Reza Hosseini-Fard; Shadi Hosseini; Habib Sadeghirad; Rahul Ladwa; Ken O'Byrne; Arutha Kulasinghe
Journal:  Curr Oncol       Date:  2022-04-24       Impact factor: 3.109

4.  Ablative Fractional Laser-assisted Low-irradiance Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients: A Prospective, Randomized, Intraindividual Controlled Trial.

Authors:  Anke S Lonsdorf; Aric Keller; Julia Hartmann; Alexander H Enk; Patrick Gholam
Journal:  Acta Derm Venereol       Date:  2022-04-13       Impact factor: 3.875

5.  Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland.

Authors:  Samuli Tuominen; Liisa Ukkola-Vuoti; Pilvi Riihilä; Jaakko S Knuutila; Veli-Matti Kähäri; Mariann Lassenius; Tuuli Ranki; Katariina Pousar; Lotta Vassilev; Sauli Vuoti; Kalle Mattila
Journal:  Acta Derm Venereol       Date:  2022-04-08       Impact factor: 3.875

Review 6.  Oral nicotinamide for non-melanoma skin cancers: A review.

Authors:  Samantha Vicki Hunt; Aaron Jamison; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

7.  Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.

Authors:  Candice Hober; Philippe Jamme; Eve Desmedt; Anna Greliak; Laurent Mortier
Journal:  Ther Adv Med Oncol       Date:  2021-05-31       Impact factor: 8.168

8.  Case Report: Successful Treatment of Cutaneous Squamous Cell Carcinoma in Three Patients With a Combination of Acitretin and Clarithromycin.

Authors:  Yan Zhao; Yanting Zhu; Haiqing Wang; Chao Ji
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

9.  Management of Acute Radiodermatitis in Non-Melanoma Skin Cancer Patients Using Electrospun Nanofibrous Patches Loaded with Pinus halepensis Bark Extract.

Authors:  Aikaterini Kyritsi; Stefanos Kikionis; Anna Tagka; Nikolaos Koliarakis; Antonia Evangelatou; Panagiotis Papagiannis; Alexandros Stratigos; Vangelis Karalis; Paraskevas Dallas; Andreas Vitsos; Efstathia Ioannou; Vassilios Roussis; Michail Rallis
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 10.  Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature.

Authors:  Michela Lai; Riccardo Pampena; Luigi Cornacchia; Giulia Odorici; Alfredo Piccerillo; Giovanni Pellacani; Ketty Peris; Caterina Longo
Journal:  Int J Dermatol       Date:  2021-08-05       Impact factor: 3.204

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.